NIH funding by institute · Fiscal year 2026
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NIAMS administered $606.5M in fiscal year 2026 across 1,271 award records to 161 institutions with $10M or more in NIH funding, up 6.7% from FY2025. University of Pennsylvania received the most, 4.6% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIAMS funding
$606.5M
+6.7% vs FY2025
Award records
1,271
Institutions funded
161
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
59
NIAMS as lead or participating institute
Top NIAMS-funded institutions, FY2026
| # | Institution | NIAMS FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | University of PennsylvaniaPhiladelphia, PA | $28.0M | +25.1% | 58 | 4.6% |
| 2 | Brigham and Women's HospitalBoston, MA | $22.0M | +20.5% | 36 | 3.6% |
| 3 | University of California, San FranciscoSan Francisco, CA | $22.0M | +1.2% | 53 | 3.6% |
| 4 | University of MichiganAnn Arbor, MI | $20.7M | +11.3% | 41 | 3.4% |
| 5 | Washington University in St. LouisSaint Louis, MO | $18.9M | +31.9% | 40 | 3.1% |
| 6 | Massachusetts General HospitalBoston, MA | $18.6M | +17.0% | 32 | 3.1% |
| 7 | University of RochesterRochester, NY | $16.3M | +54.0% | 23 | 2.7% |
| 8 | University of WashingtonSeattle, WA | $15.1M | +35.3% | 21 | 2.5% |
| 9 | NYU Grossman School of MedicineNew York, NY | $14.9M | +20.2% | 25 | 2.5% |
| 10 | University of PittsburghPittsburgh, PA | $14.3M | −18.6% | 23 | 2.4% |
| 11 | Oklahoma Medical Research FoundationOklahoma City, OK | $12.6M | +215.5% | 6 | 2.1% |
| 12 | Duke UniversityDurham, NC | $12.3M | −42.3% | 30 | 2.0% |
| 13 | Icahn School of Medicine at Mount SinaiNew York, NY | $12.2M | +7.7% | 23 | 2.0% |
| 14 | Yale UniversityNew Haven, CT | $11.8M | +5.7% | 33 | 2.0% |
| 15 | Johns Hopkins UniversityBaltimore, MD | $11.5M | +32.8% | 22 | 1.9% |
| 16 | Stanford UniversityStanford, CA | $11.0M | −5.8% | 29 | 1.8% |
| 17 | Northwestern UniversityChicago, IL | $10.7M | +17.4% | 21 | 1.8% |
| 18 | Baylor College of MedicineHouston, TX | $9.8M | +10.1% | 14 | 1.6% |
| 19 | Indiana University IndianapolisIndianapolis, IN | $8.9M | +103.1% | 15 | 1.5% |
| 20 | University of ArizonaTucson, AZ | $7.8M | +113.1% | 14 | 1.3% |
| 21 | University of California, Los AngelesLos Angeles, CA | $7.8M | +10.4% | 17 | 1.3% |
| 22 | University of FloridaGainesville, FL | $7.7M | −42.1% | 22 | 1.3% |
| 23 | University of MinnesotaMinneapolis, MN | $7.5M | −13.3% | 16 | 1.2% |
| 24 | University of Colorado Anschutz Medical CampusAurora, CO | $7.4M | −14.6% | 21 | 1.2% |
| 25 | University of Alabama at BirminghamBirmingham, AL | $6.8M | +7.5% | 18 | 1.1% |
Showing the 25 largest of 161 institutions with NIAMS funding.
Open and upcoming NIAMS funding opportunities
NOFOs led by NIAMS first, then those NIAMS participates in, soonest due date first. Browse every NIH NOFO.
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
PAR-24-279 · R61
Next due Nov 2, 2026
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
PAR-24-280 · R01
Next due Nov 2, 2026
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR-25-141 · UG3, UH3
Next due Nov 2, 2026
- NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
RFA-AR-28-001 · P30 · opens soon
Next due Feb 1, 2027
- Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)
PAR-27-074 · R03
Next due Feb 16, 2027
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
PA-25-093 · R34
Next due Feb 16, 2027
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
PAR-27-075 · R01
Next due Oct 5, 2027
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
RFA-AT-25-003 · R15 · led by NCCIH
Next due Oct 27, 2026
- HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
PAR-27-045 · R61, R33 · led by NCCIH
Next due Oct 30, 2026
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
RFA-AI-27-014 · U01 · led by NIAID
Next due Nov 9, 2026
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
RFA-AI-27-018 · R61, R33 · led by NIAID
Next due Nov 10, 2026
- Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
PAR-27-003 · RM1 · led by NIGMS
Next due Nov 17, 2026
- Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
PA-27-037 · F99, K00 · led by OD
Next due Dec 8, 2026
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
PA-25-422 · F31 · led by NIH
Next due Dec 8, 2026
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
PA-25-423 · F32 · led by NIH
Next due Dec 8, 2026
Showing 15 of 59. See all NIAMS NOFOs.
Recent NIAMS awards
The newest NIAMS award notices among the institutions above, each linked to its NIH RePORTER record.
- Multilayer coordination of stratified epithelial wound closure (opens NIH RePORTER)
University of Washington · 1R21AR088908-01 · NIAMS · Notice Sep 24, 2026
$165KR21
- Understanding the Roles of Synovitis, Knee-Adjacent Obesity and Sarcopenia in Pain Phenotypes and Structural Progression of Knee Osteoarthritis - An Analysis of the Entire Osteoarthritis Initiative (opens NIH RePORTER)
University of California, San Francisco · 1R56AR085666-01A1 · NIAMS · Notice Sep 23, 2026
$621KR56
- Role of Gq signaling for PTH1R-dependent bone growth (opens NIH RePORTER)
Massachusetts General Hospital · 1R21AR088883-01 · NIAMS · Notice Sep 23, 2026
$200KR21
- Mechanisms of Spinal Stiffening After Growing Rod Insertion (opens NIH RePORTER)
Children's Hospital of Philadelphia · 1K23AR086373-01A1 · NIAMS · Notice Sep 23, 2026
$160KK23
- Failure to resolve an adaptive stress state contributes to Duchenne Muscular Dystrophy Severity (opens NIH RePORTER)
University of Southern California · 1R21AR088867-01 · NIAMS · Notice Sep 22, 2026
$212KR21
- Nuclear Receptors In Cancer Cachexia (opens NIH RePORTER)
UTHealth Houston · 1R21AR088832-01 · NIAMS · Notice Sep 22, 2026
$201KR21
- Immunostimulatory short non-coding RNAs in systemic lupus erythematosus (opens NIH RePORTER)
Thomas Jefferson University · 1R21AR088737-01 · NIAMS · Notice Sep 22, 2026
$200KR21
- Consortium for Hereditary Epidermal Differentiation Disorders (CHEDD) (opens NIH RePORTER)
Northwestern University · 1U54AR089183-01 · NIAMS · Notice Sep 19, 2026
$1.6MU54
- Meltblown Scaffolds for Irreparable Rotator Cuff Tears: Interposition Grafting (opens NIH RePORTER)
Purdue University · 1R56AR085946-01A1 · NIAMS · Notice Sep 19, 2026
$579KR56
- A multi-omic investigation of keloid disease recurrence (opens NIH RePORTER)
Henry Ford Health + Michigan State University Health Sciences · 1R56AR087418-01 · NIAMS · Notice Sep 19, 2026
$300KR56
Looking for a postdoc in musculoskeletal and skin?
See how many musculoskeletal and skin labs received a new NIAMS R01 or R00 in the last three months, by month, state, and institution.
Newly funded musculoskeletal and skin labsQuestions about NIAMS funding
- How much does NIAMS fund?
- In fiscal year 2026, NIAMS administered $606.5M across 1,271 award records to the 161 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NIAMS's extramural awards but not its full budget.
- Which institutions get the most NIAMS funding?
- University of Pennsylvania ($28.0M), Brigham and Women's Hospital ($22.0M), University of California, San Francisco ($22.0M) led NIAMS funding in FY2026.
- How do I find an open NIAMS funding opportunity?
- This page lists open and upcoming NOFOs where NIAMS is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NIAMS program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIAID · NIA · NHLBI · NIGMS · NINDS · NIDDK · NIMH · OD · NICHD · NIDA · NCATS · NEI · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming